Therefore, inhibition of Akt/NF-κB signaling by AuNPs provides an inorganic nanomaterial based therapeutic approach for sensitizing cells to cisplatin by decreasing EMT and stemness and thus may play an important role in therapeutic management of ovarian cancer. This evidence concerns the gene NFKB1 and ovarian carcinoma.